Literature DB >> 8049126

Turnover of skeletal muscle contractile proteins in glucocorticoid myopathy.

T Seene1.   

Abstract

Muscle weakness in glucocorticoid myopathy results mainly from muscle atrophy, the reason for which is the accelerated catabolism of muscle proteins. As the content of lysosomes in skeletal muscle, particularly in fast-twitch glycolytic fibers, is relatively low the non-lysosomal pathway makes a particularly significant contribution and has special importance in the initial rate-limiting steps in the catabolism of contractile proteins and in the regulation of their turnover rate. The turnover rate of actin and the myosin heavy chain is decreased in all types of muscle fibers, and more rapid turnover of the myosin light chain is registered in the fast-twitch glycolytic and oxidative-glycolytic fibers. Exercise and simultaneous glucocorticoid treatment is an effective measure in retarding skeletal muscle atrophy and provides protection against muscle wasting.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8049126     DOI: 10.1016/0960-0760(94)90165-1

Source DB:  PubMed          Journal:  J Steroid Biochem Mol Biol        ISSN: 0960-0760            Impact factor:   4.292


  9 in total

1.  Alpha and beta glucocorticoid receptor mRNA expression in skeletal muscle.

Authors:  S H Korn; E Koerts-de Lang; G E Engel; J W Arends; E F Wouters; F B Thunnissen
Journal:  J Muscle Res Cell Motil       Date:  1998-10       Impact factor: 2.698

2.  Muscle torque relative to cross-sectional area and the functional muscle-bone unit in children and adolescents with chronic disease.

Authors:  Dale Y Lee; Rachel J Wetzsteon; Babette S Zemel; Justine Shults; Jason M Organ; Bethany J Foster; Rita M Herskovitz; Debbie L Foerster; Mary B Leonard
Journal:  J Bone Miner Res       Date:  2015-03       Impact factor: 6.741

3.  Fourth-generation model for corticosteroid pharmacodynamics: a model for methylprednisolone effects on receptor/gene-mediated glucocorticoid receptor down-regulation and tyrosine aminotransferase induction in rat liver.

Authors:  Y N Sun; D C DuBois; R R Almon; W J Jusko
Journal:  J Pharmacokinet Biopharm       Date:  1998-06

4.  A cell-autonomous role for the glucocorticoid receptor in skeletal muscle atrophy induced by systemic glucocorticoid exposure.

Authors:  Monica L Watson; Leslie M Baehr; Holger M Reichardt; Jan P Tuckermann; Sue C Bodine; J David Furlow
Journal:  Am J Physiol Endocrinol Metab       Date:  2012-02-21       Impact factor: 4.310

5.  Role of exercise therapy in prevention of decline in aging muscle function: glucocorticoid myopathy and unloading.

Authors:  Teet Seene; Priit Kaasik
Journal:  J Aging Res       Date:  2012-06-17

Review 6.  The impact of inflammation on bone mass in children.

Authors:  Wai W Cheung; Jian-Ying Zhan; Kyung Hoon Paik; Robert H Mak
Journal:  Pediatr Nephrol       Date:  2011-01-01       Impact factor: 3.714

7.  Exercise myopathy: changes in myofibrils of fast-twitch muscle fibres.

Authors:  P Kaasik; M Umnova; T Seene
Journal:  Biol Sport       Date:  2014-07-15       Impact factor: 2.806

Review 8.  Role of Myofibrillar Protein Catabolism in Development of Glucocorticoid Myopathy: Aging and Functional Activity Aspects.

Authors:  Teet Seene; Priit Kaasik
Journal:  Metabolites       Date:  2016-05-13

9.  Changes in Body Composition of Old Rats at Different Time Points After Dexamethasone Administration.

Authors:  Maire Aru; Karin Alev; Ando Pehme; Priit Purge; Lauri Õnnik; Anu Ellam; Priit Kaasik; Teet Seene
Journal:  Curr Aging Sci       Date:  2019
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.